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Abst ract
This review covers three areas ofschizophrenia research not usually addressed in residents'
curricula: smooth pursuit eye movements and genetics, orienting responses, and tardive dyskinesia.
The significance of these neurological signs is explored in terms of their clinical symptom
associations and their heuristic value. Neuroanatomical aspects of these signs is noted to be
speculatively consistent with hypofrontality and negative symptoms in schieophrenia. The author
describes the nature ofocculomotor abnormalities and discusses an applicable research study. He
summarizes relevant areas ofgenetic research including linkage analysis and marker studies and
explains some ofthe orienting response abnormalities in schizophrenia. He then examines tardive
dyskinesia.for associated clinical psychological implicationsbeyondits manifestation as a movement
disorder. Finally, the author discusses a stud)' of0'e movement abnormalities in patients with
tardivedyskinesia to illustratehow different research perspectives canbeinterwoven to tiegenetically
inherited neurological signs to the schizophrenic illness.
INTRODUCTION
This paper is a se lec tive revi ew of some areas of sch izoph re nia research which
a re no t routinely addressed in resid ent cu r ricula. The neu rol ogical d efici ts no ted in
Sm ooth Pursuit Eye Movements (SPEM), Orienting Resp on ses, a nd Tard ive Dyskine-
sia (T O) a re ofte n associa te d with a lte ra tions in sch izo phrenic symptoms and con ta in
important clues as to the na ture of wh at sch izo phre nic pat ients expe r ie nce . The
possible neuroanatomi cal locali zation s of these signs ofte n fit with da ta from newer
im aging techniques im pli cating fro n tal lob e dysfuncti on in sc hizophrenia. The
sig nifica nce of tardive dyskinesi a as so me t imes being a possibl e sign of a pa rticu la r
sym ptom a t ic subtype of schizo phre nia is re viewed in so me det ail. The overarching
th eme of thi s paper is that these various neurophysiologica l deficit s have th ei r cl ini ca l
corre la tes as well as heuristic va lu e in thinking about nosolo gical a nd neu roanat om i-
ca l issu es in schizophre nia research.
SPEAf andGenetics
SPEM research dates ba ck to 1910 . When " no rmal" peopl e a re as ked to track a
slow moving target, su ch as a child on a swing , th eir eyes do so in a smooth movement ,
that is, uninterrupt ed by j erking ca tc h-up movem ents or sacca des. Schizophrenic
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peopl e, however, do not follow target s with suc h grace . A subgroup of th em (40% to
80%) subs t itu te sacca des of va rying sizes a nd forms for smoot h pursu it ( I) . This
ph enomenon is so robust th at it has been replicat ed in every publ ished s tudy sin ce
1974 (2).
SPEl',,1 abnormalities provide a n object ive, va lid , a nd reli able ab norma lit y th at
may aid in th e highl y subject ive a r t a nd science of psychiatric d iag nosis. For exa m ple ,
schizo typa l personality disorder patients, wh en com pa red to normal people and to
peopl e with other types of person ality disorders, have a n increased incidence of
impaired eye tracking simila r to that found in schizo phrenic individual s. T his find ing
is cons iste n t with th e di agn osti c conce p tua liza tion of sch izo typal personalit y disorder
as part of a biologically based thought disorder spectrum (3) .
The term "gain" in eye tracking research refers to th e rat io of th e sp eed of the
eyeball to th e sp eed of th e target. The percent RtvlS (roo t-mean-squ a re) erro r is
sim ply a global measure of overall pursuit performance. Normal s a nd schizo phrenics
both have a decr ease in pursuit gain and an incr ease in percent RM S error when th ey
are asked to track a randomly alt ernating a nd hen ce unpredi ct abl e ta rget as opposed
to a stead ily oscillating pr edi ctable one . The unpredi ct ability res u lt s in slower
tracking a nd more mistakes in tracking as th e individual ca nnot ant icipat e a nd
eve ntua lly learn th e target 's path . Ho wever, th e type of mistak es t hat the schi zo-
phrenic makes in tracking a n unpredi ct abl e target is different t han th ose mad e by
normal s (4).
No r mals err in making both "catc h-up" a nd " loo k-a head " (an t icipatory) sa c-
cades whil e schizophre nics mak e man y "catc h-up" but relat ively few " look-a head"
sa cca des . In add ition, normals have high er pursuit ga in for both pr edi ctabl e an d
un predi ct abl e target s. The lack of a n t icipa t ion, and diminish ed velocit y to a lesser
ex te n t, mesh es nicely with spec ula t ions of frontal lob e impairm en t fro m other a reas
of schizophre nia research , namely im aging st ud ies . The diagra m in Figure I high-
lights so m e of th e neuroan atomy of smooth pursuits. The pivot al control of the
frontal eye field s is depi ct ed. Early stud ies of ce re bra l blood flow in normal ind ivid ua ls
have shown th at th ere is " hyperfro ntality" or incr eased blood flow to a n terior front al
(p re mo to r and prefrontal) regions relative to post erior fro nta l region s. Schizophr en-
ics were shown to have "hypofrontality" or a decr eased a n tero-pos ter ior flow gradi-
ent. Pr eliminary PET findings are cons iste n t with decr eased front al lobe ph ysiological
fun ctioning in schizophreni a as reflect ed in decr eased glucose utili zat ion . It is
interesting that on e study has demonstrated a relative lack of blo od flow th rough th e
dorso-lateral prefrontal cor tex wh en schizophreni c pati ents were asked to perform a
task that normally incr eas es flow to this area (5-6) . The lat e Smadar Levin, who
spec ia lized in eye tracking research , th eorized th at such a re as con tiguo us to fron tal
ce n ters of ocular con t ro l were likely implicated in sch izophrenia . As she dedu ced , th is
localization is consiste nt with other features of th e illn ess as well: " Fina lly a nd most
importantly, th e clinical frontal lob e synd ro me is the sing le organic brai n syndrom e
th at is most simila r to th e cl inica l syndrome of sch izophr e nia, particul arly of ch ro nic
'negative' sym ptoms schizophre nia (7).
While tardive dyskinesia will be discu ssed lat er in th is pap er, it is usefu l a t this
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juncture to point out that many believe th at a ll volun tary mot or activity is regul at ed
by th e prefrontal cortex and th e basal ga ng lia in conj unc t ion wit h input from th e
front al motor cor te x. Perhaps this is why so me ta rd ive dyskinetic schizophrenics, who
may have more negat ive sym pto ms a nd ca udate damage th an other sch izophre nics,
a lso have deficit s in voluntary mot or move ments (8) .
Genetics research has a lso ben efited fro m th e di scovery of the pursuit a no maly.
That this trait is inherit ed is demonstrated by th e fact t ha t 45% of the first-degree
relatives of schizophre nic individuals manifest impaired tracking, in con trast to onl y
8% to 12% of normal individual s (7,9). The signifi cance of gene tically tra nsmitt ed
t rait s is best a pprecia te d in light of so me underst anding of th e con cepts of ge ne t ic
markers a nd link age a nalysis.
A ge ne t ic marker is a stable, relatively uniq ue, obse rvable manifest ation th at is
t ransmit ted fro m ge nera tio n to ge nera tio n toget her with an illness. A marker ma y be
so me thing tot ally un relat ed to th e illness, for exam ple, red-green color blindness
( 10) . The term marker has also been a pplied to denote a di stincti ve segment of DNA
th at may be inherit ed with th e mutant disease ge ne a t a high er freq uency th an other
segme nts of th e DNA ( I I). These two definiti on s a re inti mat ely rela ted, th e main
di fference being a focus on th e ge ne versus its obs ervable expression. The closer th e
ph ysical pr oximity of th e two ge nes on a chromosome, the less likely it is that th ey will
be se pa rate d during miotic recombination , a nd hence in t hei r transm ission a mo ng
family members. When two ge nes do se pa ra te, th ey a re sa id to recombine. Thus th e
lower th e percentage of tim e th at ge nes recombine, th e close r th e gcncs are on th e
chro mosome-tha t is, th e more closely linked .
Linkage analysis provides clu es to th e chro mosomal loca tion of a defective ge ne.
Link age data is record ed by wha t is kn own as a lod score. A lod score is a loga rit hm of
a stat ist ica l probability. It s ca lcula t ion ca n be used as a n indica tor of likel ihood th at a
marke r a nd a di sease a re linked . A lod sco re of > + 3 is considered highly ind ica tive of
linkage whil e on e of < -2 indicat es th at th e traits are almost ce rtainly not linked
(11-12) .
There is a connec tion between linkage a na lysis a nd psych ophysiological markers .
Markers aid in identifyin g whi ch members of a given fa mi ly are mos t likely to have
inherit ed th e di sease ge ne , eve n whe n th ey a re clinica lly asymptomatic. A subpopu la-
t ion of ca rrie rs or peopl e at risk is th en defined t ha t can be studied in tensively with
the new technology. More pr ecisely, th eir ge nes ca n be cleaved and ana lyzed. There is
also a n underlyin g assum ption that biologically defin ed disease phenotypes will
co rre la te better with underlying ge ne t ic mak eup, whi ch a llows for a ge ne tically more
hom ogen eou s di sease population to be investigat ed (13). Finally, psychophysiologica l
markers ca n help elucida te th e mod e of t ran sm ission of t he disease gene within th e
fa mily tree. Further research may vast ly expa nd th e sco pe and accuracy of ge ne tic
counseling a nd may mak e possible th e desp erately need ed pro spect ive investigations
of people a t high risk ( 10, 14).
The natural obstacles to be overcome by research include incom plet e gen e
pen etrance, variable expressivity (the tenden cy of th e same ge ne de fec t to manifest
it self in different ways) , and ge ne t ic het erogeneit y (the sa me exact disease s ta te
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ca use d by eithe r different mutation s a t th e same ge ne site or by multiple mutations
a t many ge ne sites). Id eally, research ers try to find one bad gene causing on e disease
in on e family; in reality th ey need ve ry la rge fa milies a nd serend ipity to facilitate this
com plex search ( 12). Di scovering th e ge ne or ge nes th at cause schizophrenia is also
onl y th efirst hurdle, aft er whi ch comes th e daunt ing task of d iscovering how th e given
defect expression mani fest s itse lf in th e human brai n ( 15).
C hromo some 5 has been th e focu s of st udy at a nu m ber of research ce n te rs (16) .
A recently published case study told of a pr ob and an d his maternal uncle, both of
whom had schizophre n ia as well as the rare a no maly of a partial tri somy of
chromoso me 5. Only th e proband a nd his uncle had abnormal SPEM ; th e normal
famil y members had normal tracking. This clu stering of a nomalies suggests th at the
tri somy con t r ibu te d to th e illn ess (17). A curren t m ajor hypoth esis that eye move-
ment dysfunction (EMD) and schizophre nia are a lterna t ive expressions of th e sa me
lat ent disease trait would ex pla in why thes e con d itions can occur together as well as
se parately (18) .
In con t ras t to effor ts to find the gene t ic ca uses of schizophrenia on a particul ar
chromosome, so me th eoretical cons truc ts propose a less re du ctionistic patt ern of
inheri tance. One such exposit ion postula tes tha t schizophrenia results from th e
com plex inte racti on th at includes not only innate gen et ic trai ts, environme nta l
effec ts, a nd random ph en omena, but also incl udes a di sturba nce in the balance
bet ween th ese fact ors and th e so-ca lled normative regulat ion of t he ba ckground
ge no type . In other words, apa r t fr om the em phasis placed on finding a dis ease ge ne,
this th eor y hold s th at , in fac t, th e backg ro und ge nes a re more likely to pla y a
definit ive rol e in modifyin g t he expression of ge nes tha t mayor may not be pr esent in
normal individual s.
A simi la r mod el has proven useful in underst and ing cancer wh ere it is th ou ght
th at th e regula tor ge nes -not j us t th e oncoge nes-playa crucial ro le in det ermining
who will ac tually develop ca ncer. T he background geno type, in this theory, ac ts as a
homeost atic stabilizing influ en ce, like a res t ra in ing ne t , on genet ic a nd enviro nme n-
tal biases. If th e net is br ok en, incr eased variability ca n be ex pected . In summary, this
t he ory posit s a mod el for underst and ing th e interacti on s between genetic biases, th e
enviro nme nt, a nd th e background ge no type. Mor e specifica lly, it shows how th ey
bal an ce each othe r 's influ en ce in de termining th e behavio r ul ti ma tely manifest ed by
an organism ( 19) .
E lectrodermal Orientin g Responses
Psychophysiology involves th e study of th e ph ysiological res ponses associated
with psych ological states . One of th e mo re cons iste n t a no malous psychophysiological
respon ses of schizophre n ic patients is ca lled skin cond uctance orien ting response
(SC a R), nonrespon siveness. The ability of t he skin to cond uc t elec t r icity is slight ly
enha nce d by swea t, and this small incr ease in the skin conductance of an elec tric
curren t ca n be measured by elec t ro des (20-2 1). An orient ing response is th e
organism's first reaction to a new stim ulus; it is ass ocia ted with increased sweating
NEURO LOG ICAL SIGNS IN SCHIZO PH RENIA 31
and th ere fore with incr eased skin cond uc tance. If a stu de n t is relaxing during th e
third hour of a preoedipal rage t heory lectu re a nd someone nearby drops a pen , th en
th e stude nt's body undergoes a ph ysiological response, within approximat ely 150 ms,
to th e new st im ulus . T o det ermine "wha t's up ," th e body orients its att entional
abiliti es toward th e sound of th e pen hitting th e floor. This ph en omen on has be en
ca lled " t he most ele me n ta ry form of a tten t ion," a nd it is th e reaction that engages
th e com plex br ain a tten t ional appara tus to assess th e novel stimulus (22).
SC a R nonrespon siveness in schizophre n ic ind ivid ua ls is intuitively not surpris-
ing given th at , since Kraeplin , a tt en tio n deficien cy has been noted as a hallmark of
schizophre nia (22) . SCaR nonrespon siveness in a large subgroup of schizophreni c
patient s has been confir me d ove r a nd ove r again in Ame rican and mu ltinational
stud ies and ha s been cons ide re d "almos t uni versall y re plicable." (22) Neuroleptic
me dica t ions do not see m to affect responding sta tus alt ho ugh this issu e has not been
conclus ive ly resolved (23-24) .
The clinical m eaning of nonresponding is con t rove rsial a nd is now under ac t ive
investi gation a long seve ra l lin es of inqui ry. First is th e qu estion of wh ich clin ical
sym pto ms corre la te with this ph en omen on . In so me studies, no nresponders seem to
be more withdrawn a nd conce p tua lly disorganized (20). However, a recent att empt to
differentiat e pat ients with positive a nd negative sympto ms by respond ing sta tus
dem onstrat ed inst ead th at both positive a nd negative sympto ms may be incr eased in
nonresponders (24).
Hoping to advance underst anding of th e nature of th e deficit s in schizophreni a ,
scie nt ists a re t ryin g to det ermine at wha t level th e ab normality in att ention process-
ing lies. These pat ients appear to lack th e ability to we igh which st imulus input is
worthy of more processin g, as opposed to possessing an inability to det ect or filt er out
(22). While th ere were initially som e rep orts th at seeme d to re la te nonrespond ing to
frontal lobe dysfun cti on , more curre nt th inking is th at th e phe nomenon st ill defies
neuroanat omical localization (25) . One PET sca n pilot study, however, ha s found
elec t rode r mal non respon sive schizo phre nics have decr eased metabolic activity in
medi al supe rior front al gyri relative to responders (26).
It should be not ed also that elec t rode rmal variabl es-including th e orie nting
respon se-are being a pplied to stud ies of high-risk subjects for t he ir possible
pr ogn ostic va lue. St ud ies of th e ge ne t ic inheritance of th ese variables may elucida te
th ei r role as ge ne t ic traits associa te d with vulnerabil it y to sch izophrenia (20).
Recently, ori enting responses were measured in a sa m ple of 101 15-year-old
boys. Intriguingly a lack of a n ori enting response was found to be sign ifica nt ly more
pr eval ent among those boys who, 10 yea rs later, had acq uire d a crim inal record.
Thus, elec t rode r mal abno rmalit ies may not be spec ific to schizo phre nia (27).
Tardive Dyskinesia
Most psychiatry residents are intimately fa milia r with TD as a n involu n ta ry
movement di sorder th at th ey obse rve a nd record fr equ ently in th eir clinical work.
Less widely recogni zed is TD's signi fica nce well beyond it s effec t on body movement.
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C linicians gen erally ta ke for granted that TD is assoc ia ted wit h t he pr olonged
usc of neuroleptics. Ideally, however, a prospective study of unmed ica ted schizo-
phren ic patients should be design ed to obs erve th e fr equen cy at which t hey develop
T D. This th eoretical problem is not a trivi a l issu e. Som e evidence indicat es th at th ere
is a basel ine inciden ce of orofacial dyskinetic movem ent. This evide nce most ly,
a lt houg h not exclusive ly, comes from pren euroleptic e ra observat ions ; nevertheless,
Waddingt on and Crow (28) recently reviewed this dorm ant body of litera ture an d,
despite it s major methodological flaws, th ey found a st r iking ly uni form pr eva len ce of
cho re oa the toid movemen t in schizophre nic population s not exposed to neurol ept ics.
Sp ecifica lly, preva len ce rates varied narrowly between 5. 1% and 7.9% in all five
s tud ies, regardless of wh ether th ey were conduct ed in 1936 or 1971. Kr aepli n a nd
Bleul er, in the ea rly 1900s well before th e advent of neurolep tics, described involun-
tary chore oa the to id mov em en ts in schizophreni c persons. Ast oni shingly, th e possible
clinical relevance of this phenomenon was noted as ea rly as 1857 by G riesinger, who
wrote how " persiste n t automatic grimacing" a nd " chorea like movement s" were
indica tive of a poor prognosis in "adu lt luna t ics." (29)
Perh a ps consiste nt with thi s poor prognosis , TD may represent a n exace rba tio n
by neuroleptics of preexi sting brain damage in vulne rable pa t ien ts (30). A subgr oup
of th ese pat ients may hav e developed TD as part of th eir "schizophre nia," eve n
without neurolept ic exposure. This possibil ity provid es a n addit iona l reason for
ca re fully examining how patients who develop TD differ clinica lly from those who do
not ; th e results may shed some light on th e br ain pathology involved in their
schizophre nia .
Studies have shown th at pat ients with TD have more exte ns ive deficits in a wide
variet y of a reas than ot he r patients. They a re , ind eed , sicker.
T D patients have worsen ed smooth pursuit eye move ment. The deficit tak es the
peculi ar form of large non tracking saccades . These patien ts see m to have a d im in-
ish ed ability to att end to th e target , th en try to ca tch up by using th ese large, qu ick
eye movements (I ). In a simila r vein, so me ea rly evidence indi cat es th at TD is
associa te d with signifi cantly slowed reaction time (3 1).
A prospective study demonstrated th at patients who develop TD perform mor e
poorly on psychomet ric testing (e.g., th e WAIS) a nd have more soft neurologica l
signs tha n do non-T D pat ient s (32) . A recent pr eliminary study a lso indi cated th a t
not only is there a dir ect rela tionship between T D symptom severity a nd cognit ive
defi ci t, as measu red by the WAIS a nd Wechsler Memory Scales, but also that
orofacia l TD seems to have a st ro nger correla t ion than ex t re mity or truncal TD (33) .
Ano ther interesting preliminary study con tras ted T D pat ients with Park inson 's
pa t ien ts ; on th e tot al sca le of the Brief Psych iat ric Ra t ing Scal e (BP RS), tardive
dyskine tic patients had sign ifican t ly highe r ra tings of psychopathology (34) . Ano th er
piece of the j igsaw puzz le-alt ho ug h in a far corne r- is th e significa n tly higher
deg ree of major affe ct ive d isord er in the family history of patients with ta rdive
dys kinesia (32, 34)
In a recen t review (30) , 8 of II studies showed great er det erioration in dysk ine tic
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patients in such areas as conce ptua l level, memory, or ien ta t ion, and paired learning.
Some studies also see me d to indicat e a n as sociation between a bno rmal invo luntary
movement a nd negative sym ptoms, as well as ass ocia tions with ce r ta in CT and
pn eumoen cephalographic abno r malit ies such as a trophy a nd t he ventricle-t o-brain
ratio. Recent MRI data ind ica te tha t dyskinet ic patient s may have significa n tly
smalle r ca uda te vo lumes altho ug h no significa n t di fferen ces were found in othe r
brain a reas (35). Althou gh all th ese a reas require fu r t he r stud y, the sp ecial deficits
(o the r than involuntary movement) manifest ed by TD pa ti ents a re wo r th keeping in
mind clinicall y, if on ly to det ermine wh ether such observa t ions co rres po nd with on e 's
. .
own impressron s.
The Latin root tard m eans lat e , hen ce tardive dys kines ia ha s come to be defin ed
as those involuntary cho reoat he to id move me nts induced by neuroleptics th at usu ally
appear only a fte r several months (a t least 6) of treatment. From a research
metho do logy point of view, th ese m ovements have been class ified in seve ra l ways. In
fact , it is partly because of th e wid e va riet y of class ificat ions that facile gen eraliza-
tions from the data a re ofte n difficult to deduce. As with most ph enomena in scien ce,
th e closer we look , th e more co m plica te d sim ple thi ngs be come, and th e mo re
subclassifica t ions are need ed.
A nice illu st ra tion of this tendency is a study that exa m ine d noradren ergic
cha racte ris t ics of dyskinetic patien ts (36). Resea rch diagnostic cr ite ria (RDC) recog-
ni ze the fact tha t TD status fluctuat es. T o correct ly asc ertain th e appropria te
ca te go ry, of a myri ad of possibilities, for a patient 's di sorder (e.g., transient ,
withdrawal , persist ent , m ask ed ) , patients m us t be assessed at least twic e (3 7).
H owever, RD C classification s did not ind icate significan t differences in noradrenergic
funct ion ing a mong the 19 dyski netic patients. It was only by cre a t ing a subclassifica-
t ion of pa tients wit h wit hd rawal-exace rbated T D (a non-RDC crite r ia subclassifica-
tion ) th at sig nifica n t plasma MHPG level diffe ren ces were revealed. This distincti on
hints a t a m aj or underlyin g challe nge for TD research ; de te rm ini ng th e relationsh ip
between th e neuroleptic resp on siven ess of the movement disord er and the nature of
the di sord er it self. In bri ef, th ose patients wh ose movement disorder is sen sitive to
ne urolep t ics may have a differen t move me n t diso rder th a n those patients who se
moveme n t disorder is unaffected by neu rolept ics. In some un iqu e neuroch emical or
st ruc tural way, the latt er grou p's dysk in esia may be part of their schizophrenia , just
as in Huntington 's cho re a the m ovement di sorder is part of the same process ca us ing
the thought di sorder (38).
"Incr eas ed Sa ccadic Di stractibility in T ardive Dyskinesia: Function al Evid ence
for Subcor t ica l GABA Dysfunction ," (39) is a rece n t study tha t will be exam ined in
so me detail here to illu strate how the various neu rological signs can weave a more
full underst anding of clinical a nd neuroanatomical schizophrenic phenomena . Using
two pa radigms, the research ers studied three patient gro ups : ( I) 18 chronic schizo-
phrenic patients with TD, (2) 16 schizoph re nic patients without TD, a nd (3) 8 normal
co n t ro ls. In the first paradigm, the subj ect wa s told to look a t a ce n te r target ligh t ,
then toward a second target light wh en it was turned on. In th e second pa radi gm (an
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a nt isacc ade paradi gm) , th e subject was as ked to look in the opposit e directi on from
th e second light wh en it was turned on.
Two sco res were obtaine d : la tency in milli seconds an d a d istractibility sco re . T he
lat en cy sco re was th e t im e it took for th e patient 's eyes to sta rt to move. The
distractibility sco re sim ply was t he number of ti mes, in th e second paradi gm , t hat the
pa t ien t mistaken ly looked towa rd rat her th a n away from th e distracting light. For
purposes of data an alysis, the latency sco res were divided in to two ca tegories :
reflex ive a nd volit ional. Reflexive lat e ncies were th ose made in th e first paradi gm
(witho u t distracti on ) a nd th ose made to th e wrong side in th e second paradi gm
(whe n th e patient mist ak enly looked toward th e di st ract ing light inst ead of away
fro m it ) . Voliti on al la te ncy conce rned th ose saccades mad e consc ious ly a nd correct ly
away fro m th e distracting st im ulus as had been requ est ed an d practi ced . These
resp on ses were termed volitiona l becau se th e patients successfully willed th eir eyes to
avoid reflexi vely looking a t th e distraction.
Schizophre nic patients a nd norma l individuals did not differ sign ificantly in th eir
reflexi ve saccadic laten cy. Ea ch of th em too k th e sa me a mo unt of time to process and
effec t mot ori cally reflexive movem ent. However, schizo phrenic patient s, regardless
of th ei r TD status, took significan tly longer th an con trols to make cor rec t, volition al
saccades. Moreover, a ll schizo phre nic patients made more e rro rs on t he secon d
parad igm th an the cont ro ls did . But a mo ng th e schizoph renic pat ients, those with
tardive dyskinesia had distractibil ity sco res twice as high as non-TO patients. These
res u lts were replicated in a follow-up study th at a lso exa mined SPEN!. The a u tho rs
foun d no re po r te d qu anti tative d iffe rences be tween dys kin et ic a nd nondyskine tic
sch izophre nic pat ients in SPEM (40), alt hough this finding is not in acco rd with th at
of a nothe r st ud y ( I ).
Resid ents a re probabl y wonde ring , "Wha t do es all th is mean?" The st udy shows
in a n objective, qu antifiab le, ve r ifiable way, how schizop hren ic patients differ from
normal peopl e. Similarly, th e findings differentiat e pa ti en ts with tard ive dyskinesia
fro m patients without tardive dysk inesia ; th e TD pat ients bei ng more distractible. By
underst anding th e m ech anism s and meanings behind th ese di ffe rences, we can ga in a
better a pprec ia t ion of both th e br ain lesions and th e ac tua l experiences of our
patients.
So me as pects of this study she d light on th e natu re of bra in lesion s. As Figure I
illustrat es , th e con t ro l of saccadi c eye movements is com plex. In fac t, in addi tion to
th e connect ions depi ct ed, posteri or parietal region s of th e cor tex are also involved.
The reflexiv e sacc ade s a re probab ly med iated by areas of th e supe rior collicu lus and
below in th e br ain s te m. Becau se both schizophre nic a nd normal ind ivid ua ls had
unimpaired reflex ive saccades, it is less likely th at th ese lower areas a re affe ct ed in
schizophre nia . However, th e study did find th at volitional saccades too k longer for
schizo phre n ic patients th an for normal peopl e . The lit e ra tu re im plica ti ng front al a nd
pos terior pariet al region s in th e et iology of schizophre n ia is voluminous, as is th e
lit e ratu re implicating subco r t ica l a reas of th e br ain. Da mage to these ce nt ra l
processing a reas could account for th e delayed reacti on s of sch izophreni c patien ts,
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FEF Frontal Eye Fields
St - Striatum
SNR - Substantia Nigra Pars Reticulata
SC - Superi or Colli culus
MRF - Mesencephalic Reticu lar Form ation
PPRF - Paramedian Po ntine Reti cular Form ation
FIGURE 1. Neuroanatomy of saccadic eye movements. FEF, frontal eye fields ; ST,
striatum; SNR, substantia nigra pars reticulata; SC, superior colliculus; MRF, mesen-
cephalic reticular formation; PPRF, paramedian pontine reticular formation.
and it could a lso accoun t for a second find ing- th a t schizophrenics showed mor e
distracti bility than controls.
As to why tard ive dys kin et ic sch izo phren ic pat ient s showed more distractibility
tha n nondyskinet ic schizo phre nic pa ti ents, t he researchers posi ted a disruption of a
specific pathway known as th e nigrotect ile pathway. Ne uroana to m ica lly, th is pathway
connec ts th e substania nigra reticul ata to th e supe rior co lliculus (see th e diagram).
Support of this neuroan atomical locali zat ion comes from animal studies in whi ch a
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transecti on of this pathway in monkeys results in saccad ic d ist rac tibility. A bri ef
sum mary of the presumed neuroch emist ry of tardive dyskinesia in general ma y help
to expla in why this GABAnergic pathway is th e hypothesized a rea of da mage in TD
patients.
Theori es about th e neuroch emical basis of TD have evolved from schemes that
conside r onl y on e neurotransmitter syste m- na me ly dopamine- to those tha t postu-
lat e com plex interacti on s a mong dop amine, GABA , norepinephrin e, and serotonin
pathways. C lassically, th e neuroleptic's well- est ablish ed blockage of dopamine a t th e
syna pse was th ou ght to result in th e "che mical dene rvat ion supersensitivity" of
dop amine receptors, which, wh en st im ula te d, evo ked invo luntary movement (4 1).
In con sist en cies in th e expe rime ntal evide nce fr om a nimal, hu ma n pos tmort em, a nd
th erapeutic trial s have proven this sche me reducti onistic. For exa m ple , since all
patients quickl y develop denervation supe rse ns it ivity from neurol ep t ics, why do only
a fr acti on develop TD? Why th e tim e lag with th e side effect some tim es surfacin g
onl y a fte r len gthy exposure over t ime to neuroleptic drugs (4 1-42)? C learly, mor e
com plex expla na tions a re required.
Sp ecul ation abou t norepinephrine 's rol e in TD has led to tria ls of propranolol
hyd rochl oride and cIonidine hyd rochl oride (36) for it s control. In this study, th e
influen ce of GABA dysr egul ation is highlight ed . Ea rly evide nce indicat es th at GABA
in th e SN R is decreased in dysk ine t ic, but no t in non dys kin eti c, neurolepticized
monkeys. The SNR to SC pathway is a maj or efferent GA BA pathway linking th e
basal ga ng lia to eye movement. C utt ing this pathway in monkeys resul ts in saccadi c
distractibility that is perhaps a na logo us to th e distract ibilit y noted in human
patients. It remains to be seen whether a nimal mod els will be cor re la ted wit h human
expe rie nce, but eye -move me nt study mak es it s con t r ibu t ion in this con text. In bri ef,
this study demonstrates a defect in th e human fun ctioning of th e GA BAnergic
pathway that is present se lec t ive ly in pa ti ents with ta rdive dyski nesia . C linica l trials
of GABA agonists to treat TD a re con t inuing, with so me promising ea rly results
(4 1-44) .
So me research ers beli eve th at in th e sa me way den ervat ion supersensitivity of
st r iatal dop aminergic region s may, in so me cases, result in TD, neurolept ic den erva-
tion of mesolimbic or other non striat al region s may result in a supersensitivity
psychosis. In this th eoretical subg ro up, withdrawal of ne uro lept ics results in a sudde n
worsening of psychosis (a nd possibl y dyskinesia as well ) with rapid im provement if
medication is restored . These patients may display " to le ra nce" to neurolept ics (i.e. ,
they require progressively higher do ses to maintain th e sa me th erap eutic effect). In
brief, a perniciou s and persist ent cha nge in th e patient 's di sease is induced (45-47).
CONCLUSION
The research lit erature indicat es th at patients who suffe r from the movement
disorder tardive dyskinesia te nd also to suffer fro m more severe defi cit s in th eir
psychological expe rience s (48). This ph enomenon may be reflected clinically by a
pr edominance in th ese patients of negative symptoms a nd cog nitive dysfunction
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(30,8,49-52) . Efforts to underst a nd schizophrenia as a neu ro psychological en tity can
be enha nce d by a pprecia t ing th e ties be tween th e ne urologica l signs dis cussed and
th e clinica l syndrome. Locali zing the sch izophrenic's lesions with newer im agin g
techniqu es has ofte n implicated frontal lobe dysfun ct ion , a region possib ly implicat ed
by th ese signs as well. Kn owled ge of th e biological evide nce supporting th e clinica l
pictu re sho uld enha nce resid ent clinicia ns' understanding of th e nature of th ei r
patients' afflict ions .
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